Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas

International Journal of Cancer

Volumn 118, Issue 5, 2006, Pages 1154-1158

  Pimenta, Flávio J ^a   Gomes, Dawidson A ^a   Perdigão, Paolla F ^a   Barbosa, Alvimar A ^b   Romano Silva, Marco A ^a   Gomez, Marcus V ^a   Aldaz, C Marcelo ^c   De Marco, Luiz ^a,d   Gomez, Ricardo S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Luxemburgo   (Brazil)

^c UNIVERSITY OF TEXAS   (United States)

^d NONE   (Brazil)

Author keywords

Fragile sites; Oral squamous cell carcinoma; Tumor suppressor gene; WWOX

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; OXIDOREDUCTASE; RNA; UNCLASSIFIED DRUG; WWOX PROTEIN;

ARTICLE; CHROMOSOME 16Q; DNA SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WWOX GENE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; OXIDOREDUCTASES; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 31844432243     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21446     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers. Int J Cancer 1993;54:594-606.
2. Toruner GA, Ulger C, Alkan M, Galante AT, Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN, Dermody JJ. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 2004;154: 27-35.
3. ARF in patients with severe oral epithelial dysplasia. Cancer Res 2002;62:5295-300.
4. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRAJ6D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 2000;9:1651-63.
5. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 2000;60:2140-5.
6. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 2001;61:8068-73.
7. Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol 1999;17:1618-24.
8. Popescu NC. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett 2003;192:1-17.
9. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
10. Mineta H, Miura K, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Ito M, Wennerberg J. Low expression of fragile histidine triad gene correlates with high proliferation in head and neck squamous cell carcinoma. Oral Oncol 2002;39:56-63.
11. Tai SK, Lee JI, Ang KK, El-Naggar AK, Hassan KA, Liu D, Lee JJ, Ren H, Hong WK, Mao L. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication. Clin Cancer Res 2004;10:5554-7.
12. Richards RI. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 2001;17:339-45.
13. Sozzi G, Sard L, De Gregorio L, Marchetti A, Musso K, Buttitta F, Tornielli S, Pellegrini S, Veronese ML, Manenti G, Incarbone M, Chella A, et al. Association between cigarette smoking and FHlT gene alterations in lung cancer. Cancer Res 1997;57:2121-3.
14. Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM. Altered expression of FHIT in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000;60:1177-82.
15. Stein CK, Glover TW, Palmer JL, Glisson BS. Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer 2002;34:333-40.
16. Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol 2002;38:610-7.
17. Kuroki T, Trapasso F, Shiraishi T, Alder H. Mimori K, Mori M, Croce CM. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res 2002;62:2258-60.
18. Greene FL, Page DL, Fritz A, Balch CM, Haller DG, Marrow M, eds. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002.
19. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
20. Maier JA, Voulalas P, Roeder D, Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 α antisense oligomer. Science 1990;249:1570-4.
21. Ludes-Meyers JH, Bednarek AK, Popescu NC, Bedford M, Aldaz CM. WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet Genome Res 2003;100:101-10.
22. Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 1997;72:408-11.
23. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Por-teous DJ, Smyth JF, Gabra H, Watson JE. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA 2001;98:11417-22.
24. Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, Huebner K, Edmonds P, Croce CM. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 2004;10:3053-8.
25. Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M, Saito Y, Ozawa K, Croce CM, et al. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Mol Cancer Res 2003;1:940-7.
26. Yendamuri S, Kuroki T, Trapasso F, Henry AC, Dumon KR, Huebner K. Williams NN, Kaiser LR, Croce CM. WW domain containing oxidoredutase gene expression is altered in non-small cell lung cancer. Cancer Res 2003;63:878-81.
27. Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer 2004;91:753-9.
28. Guler G, Uner A, Guler N, Han S, Iliopoulos D, Hauck WW, McCue P, Huebner K. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 2004;100:1605-14.
29. Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, Rattan S, Cesari R, Nolli ML, Williams NN, Mori M, Kanematsu T, et al. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 2004;10:2459-65.
30. Iliopoulos D, Guler G, Han SY, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R, Huebner K. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 2005;24:1625-33.